This white paper is a result of a roundtable that was initiated and funded by Angelini Pharma UKI Ltd and conducted by HSJ Information, and explores the challenges and opportunities in epilepsy care, with a focus on treatment-resistant epilepsy.
Developed through an expert clinical roundtable held in July 2025, including healthcare professionals, patient representatives, and Epilepsy Action, it reflects shared insights and best practices from across the UK.
The paper highlights the burden on individuals and the healthcare system, and outlines strategic improvements aligned with the NHS 10-Year Health Plan. Key themes include prevention, equitable access, community-based care, and the integration of digital tools and AI to support more efficient, patient-led epilepsy services.
Please click on the report image opposite to view the full report.
October 2025. MAT-UKI-0364-NP
Sponsored by Angelini Pharma
